Clinical trial

A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis.

NCT00502853

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-10-25

PhasePHASE4

Study timeline

Study start (actual)2007-10-25Date precision: day

Registry last updated2017-08-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

rituximab [MabThera/Rituxan]DRUG

MethotrexateDRUG · verified · RxNorm: methotrexate

Sponsors & collaborators

Hoffmann-La Rochelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00502853 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.